ArticleMedicine2021

A randomized controlled trial protocol of the cardiovascular safety and efficacy of liraglutide in the treatment of type 2 diabetes.

Ying Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.